Bartter's syndrome is a rare inherited disorder characterized by defective kidney function, leading to significant electrolyte imbalances. It is associated with hypokalaemia, though hypertension is notably absent, which differentiates it from other kidney-related disorders.
About
- Characterized by low potassium (hypokalaemia).
- Normal or low blood pressure.
- Often mimics the effects of the diuretic Furosemide (Lasix in the US).
Aetiology
- Defects in three tubular transport proteins have been identified.
- The most common defect affects the Na-K-Cl co-transporter in the thick ascending limb of the loop of Henle.
- This leads to impaired Na+ and Cl− reabsorption, which results in:
- Increased excretion of potassium (K+) and hydrogen ions (H+), causing hypokalaemia and metabolic alkalosis.
- Increased production of prostaglandins, which contribute to electrolyte imbalances.
- Hyperplasia of the juxtaglomerular apparatus (JGA), leading to elevated levels of renin and aldosterone.
Clinical Features
- Infants present with signs of tiredness and lethargy due to low potassium levels.
- Failure to thrive is common in children.
- Muscle weakness, fatigue, and constipation due to electrolyte disturbances.
- Normal or low blood pressure, unlike other hyperaldosteronism conditions, which typically present with high blood pressure.
- May present as a rare cause of growth failure in childhood or adolescence.
Investigations
- Elevated levels of renin and aldosterone.
- Hypokalaemic metabolic alkalosis (low potassium and elevated blood pH).
- Hypocalcaemia (low calcium) and hypercalciuria (excess calcium in urine).
- Defective Na/K/Cl co-transporter in the thick ascending limb of the loop of Henle.
- Normal or low blood pressure.
Differential Diagnosis
- Chronic vomiting or diarrhoea.
- Diuretic abuse.
- Magnesium deficiency.
- Gitelman syndrome (another renal tubular disorder but with hypomagnesemia).
Management
- Supplementation of sodium (Na) and potassium (K) to address electrolyte imbalances.
- Use of potassium-sparing diuretics, such as Spironolactone or Amiloride, to reduce potassium loss.
- Administration of NSAIDs (e.g., Indomethacin) to reduce prostaglandin production.
- Consider ACE inhibitors or angiotensin receptor blockers (ARBs) to reduce renin and aldosterone levels if necessary.